Sinovac vaccine is “effective and safe” in children as young as 3 years old

After his own phase I and II clinical trials in 500 people aged 3 to 17 years, the pharmacist Sinovac announced that CoronaVac, its inoculant against COVID-19, is effective in children and adolescents.

These 500 volunteers received an injection of two medium or low doses of vaccine or a placebo and, according to what was revealed by the pharmacist, most of the side effects “they were sweet“Only two children aged 3 to 6 developed a high fever during vaccine trials, according to Gang Zeng, a researcher for the pharmaceutical company.

It is estimated that around 70 million people have been vaccinated against the coronavirus using this drug. Among these many people is, for example, the President of Chile Sebastian piñera, who on March 12 completed her vaccination with the second dose.

For now, phase III trials of the vaccine developed by Sinovac Biotech in foreign countries have not included minors, so it is expected that, with the recently announced results, they will begin in the coming weeks.